Cargando…

Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients?

Detalles Bibliográficos
Autores principales: Robertsen, Ida, Woillard, Jean‐Baptiste, Åsberg, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688523/
https://www.ncbi.nlm.nih.gov/pubmed/31144343
http://dx.doi.org/10.1111/bcp.13984
_version_ 1783613719988666368
author Robertsen, Ida
Woillard, Jean‐Baptiste
Åsberg, Anders
author_facet Robertsen, Ida
Woillard, Jean‐Baptiste
Åsberg, Anders
author_sort Robertsen, Ida
collection PubMed
description
format Online
Article
Text
id pubmed-7688523
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-76885232020-12-09 Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients? Robertsen, Ida Woillard, Jean‐Baptiste Åsberg, Anders Br J Clin Pharmacol Letters to the Editor John Wiley and Sons Inc. 2019-05-29 2020-12 /pmc/articles/PMC7688523/ /pubmed/31144343 http://dx.doi.org/10.1111/bcp.13984 Text en © 2019 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Letters to the Editor
Robertsen, Ida
Woillard, Jean‐Baptiste
Åsberg, Anders
Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients?
title Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients?
title_full Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients?
title_fullStr Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients?
title_full_unstemmed Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients?
title_short Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients?
title_sort why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients?
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688523/
https://www.ncbi.nlm.nih.gov/pubmed/31144343
http://dx.doi.org/10.1111/bcp.13984
work_keys_str_mv AT robertsenida whydoseadjustsystemicexposurewhenlookingforassociationswithadverseeventsintacrolimustreatedtransplantrecipients
AT woillardjeanbaptiste whydoseadjustsystemicexposurewhenlookingforassociationswithadverseeventsintacrolimustreatedtransplantrecipients
AT asberganders whydoseadjustsystemicexposurewhenlookingforassociationswithadverseeventsintacrolimustreatedtransplantrecipients